Leinco Technologies, Inc.'s Anti-Human CD194 (CCR4) (Mogamulizumab) - Custom monoclonal antibody. The Anti-Human CD194 (CCR4) (Mogamulizumab) - Custom Antibody was generated using CCR4 as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, Precipitation, ELISA, Flow Cytometry, Functional Assay, Immunoprecipitation, and Western Blot.